Chen; Isan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; Isan.The latest application filed is for "androgen receptor modulator and uses thereof".

Company Profile

3.8.11

Chen; Isan - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Androgen Receptor Modulator And Uses Thereof App 20210177821 - Chen; Isan ; et al.	2021-06-17
Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer App 20210000812 - Chen; Isan	2021-01-07
Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer Grant 10,849,888 - Chen December 1, 2	2020-12-01
Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer Grant 10,799,488 - Chen October 13, 2	2020-10-13
Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer Grant 10,799,489 - Chen October 13, 2	2020-10-13
Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer App 20190269667 - Chen; Isan	2019-09-05
Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer App 20190269668 - Chen; Isan	2019-09-05
Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer App 20180318277 - Chen; Isan	2018-11-08
Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer Grant 10,052,314 - Chen August 21, 2	2018-08-21
Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer Grant 10,034,860 - Chow Maneval , et al. July 31, 2	2018-07-31
Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer App 20180110764 - Chen; Isan	2018-04-26
Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer Grant 9,884,054 - Chen February 6, 2	2018-02-06
Estrogen Receptor Modulator For The Treatment Of Locally Advanced Or Metastatic Estrogen Receptor Positive Breast Cancer App 20170239219 - Chow Maneval; Edna ; et al.	2017-08-24
Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer Grant 9,675,586 - Chow Maneval , et al. June 13, 2	2017-06-13
Androgen Receptor Modulator And Uses Thereof App 20160220548 - CHEN; ISAN ; et al.	2016-08-04
Androgen receptor modulator and uses thereof Grant 9,340,524 - Chen , et al. May 17, 2	2016-05-17
Estrogen Receptor Modulator For The Treatment Of Locally Advanced Or Metastatic Estrogen Receptor Positive Breast Cancer App 20150157606 - Chow Maneval; Edna ; et al.	2015-06-11
Androgen Receptor Modulator And Uses Thereof App 20140199236 - CHEN; ISAN ; et al.	2014-07-17
Anti-androgens For The Treatment Of Non-metastatic Castrate-resistant Prostate Cancer App 20140088129 - Chen; Isan	2014-03-27

Company Registrations

SEC

0001586218

CHEN ISAN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.